ELEVATION ONCOLOGY INC

CUSIP: 28623U101 Class: Common Stock

Aisling Capital Management LP's Holding History (CIK: 0001766721)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 2,834,910 Value ($000) $1,041 Avg Close — Range —
Q1 2025
Shares 2,834,910 Value ($000) $735 Avg Close — Range —
Q4 2024
Shares 2,834,910 Value ($000) $1,588 Avg Close — Range —
Q3 2024
Shares 2,834,910 Value ($000) $1,701 Avg Close — Range —
Q2 2024
Shares 2,834,910 Value ($000) $7,654 Avg Close — Range —
Q1 2024
Shares 2,834,910 Value ($000) $14,543 Avg Close — Range —
Q4 2023
Shares 2,834,910 Value ($000) $1,522 Avg Close — Range —
Q3 2023
Shares 2,834,910 Value ($000) $1,878 Avg Close — Range —
Q2 2023
Shares 2,834,910 Value ($000) $4,309 Avg Close — Range —
Q1 2023
Shares 2,834,910 Value ($000) $5,386 Avg Close — Range —
Q4 2022
Shares 2,834,910 Value ($000) $2,693 Avg Close — Range —
Q3 2022
Shares 2,834,910 Value ($000) $3,203 Avg Close — Range —
Q2 2022
Shares 2,834,910 Value ($000) $3,969 Avg Close — Range —
Q1 2022
Shares 2,834,910 Value ($000) $7,144 Avg Close — Range —
Q4 2021
Shares 2,834,910 Value ($000) $17,066 Avg Close — Range —
Q3 2021
Shares 2,834,910 Value ($000) $22,084 Avg Close — Range —
Q2 2021
Shares 2,834,910 Value ($000) $38,470 Avg Close — Range —